Antitumoral bioconjugates of hyaluronic acid or its derivatives obtained by indirect chemical conjugation

Details for Australian Patent Application No. 2006274992 (hide)

Owner Fidia Farmaceutici S.p.A.

Inventors Renier, Davide; Bettella, Fabio

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2006274992

PCT Pub. Number WO2007/014784

Priority PD2005A000242 03.08.05 IT

Filing date 2 August 2006

Wipo publication date 8 February 2007

Acceptance publication date 8 March 2012

International Classifications

A61K 47/48 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates

C08B 37/08 (2006.01) Preparation of polysaccharides not provided for in

C08L 5/08 (2006.01) Compositions of polysaccharides or of their derivatives not provided for in group or

Event Publications

28 February 2008 PCT application entered the National Phase

  PCT publication WO2007/014784 Priority application(s): WO2007/014784

8 March 2012 Application Accepted

  Published as AU-B-2006274992

5 July 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006274995-Triflusal-containing polymers for stent coating

2006274986-Device for the treatment, particularly galvanization, of substrates